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Abstract 
HCPR OF PORPHYROMONAS GINGIVALIS UTILIZES HEME TO BIND NO 
By: B. Ross Belvin, B.S. 
A thesis submitted in partial fulfillment of the requirements for the degree of Master of 
Science at Virginia Commonwealth University. 
Virginia Commonwealth University, 2014 
Major Director: Janina P. Lewis, Ph.D., Philips Institute for Oral Health Research 
The obligate anaerobe Porphyromonas gingivalis is the etiological agent 
responsible for periodontal disease. It must withstand high levels of reactive nitrogen 
species in the oral cavity generated by the host and other oral flora. The mechanisms 
allowing for protection against such stress remain poorly understand. HcpR is an FNR-
CRP family regulator that has been implicated in regulation of the nitrosative stress 
response. In this study we characterize the biochemical properties of HcpR. It is a 
homo-dimer that is composed of 3 domains – a heme-binding domain, dimerization 
helix, and a DNA-binding domain. Our studies show that HcpR binds the heme cofactor. 
UV-Vis and Raman spectroscopy reveal that the bound heme is capable of binding the 
diatomic gas molecule Nitric Oxide (NO)-a source of nitrosative stress. Binding of NO 
causes a change in the oxidation state of the iron. SAXS reveals the protein bears a 
structural resemblance to homology models generated from an ortholog.  Promoterr 
studies reveal that mechanisms P. gingivalis-HcpR uses to modulate expression are 
novel and different than those found in E. coli and P. aeruginosa.
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Chapter 1 – Background Significance 
1.1 Periodontal Disease 
 The wet and warm environment of the mouth is an excellent habitat for microbes 
to live. The oral cavity is home to over 700 different species of bacterium, most of which 
are commensal (Hasegawa, Mans et al. 2007). The mouth provides a variety of 
surfaces for bacterial colonization; most are freely exposed however there are a number 
of protected “pockets” on the occlusal surfaces of teeth, gaps between teeth, and on the 
gingival margin. The accumulation of a bacterial biofilm on teeth is termed “dental 
plaque” and there is an estimated 1011 organisms per gram of plaque (Gibbons, Houte 
1975, Darveau, Tanner et al. 1997). 
 Under normal homeostatic conditions, there is a balance between the host 
immune response and the normal oral flora. This equilibrium is not indiscriminate but a 
highly evolved process: the dental bacteria have adapted to living and growing in the 
selective conditions of the mouth and the host immune response limits growth via a 
combination of innate and adaptive immune responses. Under certain conditions, such 
as immune deficiency, oral bacterium can trigger the inflammatory response.  When the 
balance between the oral flora and the host response is upset the oral homeostasis is 
disrupted, the loss of this homeostatic interaction leads to the development of 
periodontal diseases (Darveau, Tanner et al. 1997). Porphyromonas gingivalis, a 
bacterium that is commensal in small concentrations in health individuals, is implicated 
as the prime etiological agent and is largely responsible for the inflammatory response 
seen in patients with periodontitis. 
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 Periodontitis is defined as the presence of gingival inflammation at sites where 
there has been a pathological detachment of collagen fibers from the cemmentum and 
loss of the junctional epithelium. Put simply, it is an inflammatory disease that affects 
the tissues that surround and support the teeth. It is characterized by the loss of 
alveolar bone around the teeth which can lead to loosening and eventual loss of teeth if 
left untreated. Bacterial plaque occupies the periodontal pockets and attaches to the 
root surfaces. Coupled with the production of enzymes and toxins, bacteria penetrate 
the epithelium which leads to initiation and sustainment of the inflammatory response 
(Saglie, Newman et al. 1982). Periodontitis is diagnosed via clinical examination of the 
tissue surrounding the teeth and an X-ray radiographic examination to evaluate the 
bone loss surrounding the teeth (Savage, Eaton et al. 2009).    
 It is estimated that 47.2% of adults aged 30 years and older have some form of 
periodontal disease: 8.7% mild, 30.0% moderate, and 8.5% severe. The risk of 
obtaining a periodontal disease increased with age: it is estimated that 70.1% of adults 
65 years and older have some form of periodontal disease (Eke, Dye et al. 2012).   
Furthermore, it has been shown that patients with immunodeficiency are at a much 
higher risk for chronic periodontal diseases (Klein, Harris et al. 1984). The side effects 
of a chronic periodontal disease have shown to increase the risk of stroke (Buhlin, 
Mäntylä et al. 2011) and heart disease (D'Aiuto, Parkar et al. 2006, Beck, Garcia et al. 
1996). 
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1.2 Porphyromonas gingivalis 
  Porphyromonas gingivalis is a rod-shaped, non-motile, Gram-negative 
anaerobic, pathogenic bacterium that forms black colonies on blood agar plates. P. 
gingivalis is the primary etiologic agent of periodontal disease (Slots, Bragd et al. 1986). 
Although it is found predominantly in the mouth, P. gingivalis and other members of the 
phylum Bacteroidetes can also be found in the GI tract, respiratory tract, and colon 
where they can serve as opportunistic pathogens. P. gingivalis does not use sugars as 
a source of energy, instead it metabolizes peptides and other nitrogenous compounds 
as a source of energy, and thus it is an asaccharolytic bacterium that is dependent on 
its proteolytic properties for energy. In the process it generates a micro-environment 
abundant in ammonia and other important nitrogenous metabolic byproducts (Boutrin, 
Wang et al. 2012). P. gingivalis exhibits similarity to other medically relevant bacterium 
such as Bacteroides fragilis, Prevotella intermedia and Tannerella forsythia making it an 
excellent model bacterium to study.  
 Porphyromonas gingivalis is theorized to be “keystone pathogen”. The keystone 
pathogen hypothesis states that certain low-abundance microbial pathogens can 
orchestrate inflammatory disease by remodeling a normally benign microbiota into a 
dysbiotic one (Hajishengallis, Darveau et al. 2012). Recent studies have shown that P. 
gingivalis has evolved methods to evade components of the host immune system. 
Instead of acting directly as the sole pro-inflammatory bacterium, P. gingivalis impairs 
innate immunity in ways that alter the growth of the entire oral biofilm. These actions by 
the bacterium change the normally homeostatic host-biofilm cross talk, promoting a 
destructive, inflammatory shift in the host-biofilm interaction eventually leading to 
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periodontal diseases. P. gingivalis alone is not sufficient to cause periodontal disease, 
suggesting that the dysbiosis caused by P. gingivalis is the cause for the disease 
(Hajishengallis, Liang et al. 2011). Furthermore, this suggests that removal or targeting 
of the keystone pathogen is a possible way of treating periodontitis.   
 With the progression of periodontitis, P. gingivalis colonizes in the sub-gingival 
and gingival crevices and invades periodontal pockets. The toxins and proteases 
secreted by the bacterium further help to stimulate a pro-inflammatory response leading 
to the breakdown of oral epithelial tissue and bone. P. gingivalis’ localization in the 
periodontal pockets further increases the release of inflammatory cytokines (such as IL-
1 and TNF), matrix metalloproteinase, and reactive nitrogen and oxygen species by the 
immune system leading to further degradation of oral tissue (Graves, Cochran 2003). 
 Although the sub-gingival area and periodontal pockets are the favored niche of 
P. gingivalis it is exposed to hostile conditions in these areas. To be able to not only 
survive but grow in these conditions P. gingivalis has developed stress defense 
mechanisms for oxidative stress, nitrosative stress, and immune response evasion 
mechanisms. Furthermore, the environmental conditions in the mouth (pH, temperature, 
iron concentration, oxygen tension) are constantly changing. These stress responses 
are important for the virulence of P. gingivalis. Without the ability to adapt, the bacteria 
cannot survive in the oral cavity or inside host cells and cannot cause periodontal 
disease (Lewis et al. 2010, Lewis, Yanamandra et al. 2012, Boutrin, Wang et al. 2012).  
Although P. gingivalis has primarily been implicated in periodontal disease, it has 
also been shown to cause disease states in other areas of the body. The bacterium has 
been implicated in rheumatoid arthritis; patients with rheumatoid arthritis have an 
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increased incidence of periodontal disease (Ogrendik, Kokino et al. 2005). High levels 
of P. gingivalis have been found in the amniotic fluid of women with premature labor and 
spontaneous abortion (Leon, Silva et al. 2007). 
1.2.1 Virulence factors of Porphyromonas gingivalis 
 Porphyromonas gingivalis’ role as a pathogenic bacterium has been studied 
extensively. To carry out this role, the bacterium has many tactics and virulence factors 
at its disposal. These factors help improve adherence mechanisms, regulate eukaryotic 
signals, and contribute to its virulence. Combined, they are essential to P. gingivalis’ 
role in the development of periodontal disease.  
Two types of fimbriae are found on P. gingivalis, major (long) and minor (short), 
both of which are important for attachment and adherence of the bacterium. Both major 
and minor fimbriae are immunogens involved in stimulating the inflammatory response 
of the host in periodontal disease. Major fimbriae are long, filamentous proteins on the 
cell surface that adhere to host tissues. They are capable of binding to various host 
cells such as epithelial cells and blood cells, causing the release of inflammatory 
cytokines (Amano, Nakagawa et al. 2004, Enersen, Nakano et al. 2013). Minor fimbriae 
are short proteins that are important in coadhesion and biofilm formation (Park, 
Simionato et al. 2005). Another important component of the outer membrane vesicle are 
lipopolysaccharides (LPS). Much like fimbriae, LPS can interact with host cell and host 
cell receptors and is an important inducer of the immune response (Grenier, Bertrand et 
al. 1995). 
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As previously stated, P. gingivalis is an asaccharolytic bacterium, meaning that it 
is incapable of using sugars or polysaccharides as an energy source and must use 
peptides. The bacterium secretes proteases as means to obtain the required nutrients 
for growth. These proteases are called gingipains and are secreted or membrane 
associated. There are two main types of gingipains: an Arg specific- which cleaves the 
carboxy peptide bond of an arginine residue, and a Lys-specific – which cleaves the 
carboxy peptide bond of a lysine residue (Okamoto, Misumi et al. 1995). The proteases 
are involved in nutrient acquisition, heme uptake, periodontal disease progression, and 
immune response evasion (Lewis 2010, Okamoto, Kadowaki et al. 1996, Belibasakis, 
Bostanci et al. 2007). 
1.2.2 Interactions of Porphyromonas gingivalis with host cells. 
Porphyromonas gingivalis is an invasive species of bacteria and has been shown 
to invade gingival epithelial cells in vivo (Lamont, Yilmaz 2002). Although the specific 
mechanisms are not known, the act of invading epithelial cells requires rearrangement 
of the cytoskeleton and the use of bacterial virulence factors. Fimbriae and adhesins 
expressed on the surface of P. gingivalis bind to surface receptors on epithelial cells 
where the rearrangement of microtubules and microfilaments is induced. The bacterial 
cell is engulfed into the epithelial cell where it can reproduce (Yilmaz, Watanabe et al. 
2002). Furthermore, it is believed that bacterial secreted proteases play a role in 
invasion, although their exact function is not known. 
Invasion plays an important role in the development of chronic periodontitis.  
Invasion into host cells is a tactic that has been adopted by other pathogenic bacteria. 
Its location inside the cell allows it to escape the effects of the immune system and 
   
7 
 
protects it from other stresses such as antibiotics. Hidden away inside the eukaryotic 
cell, P. gingivalis is afforded the opportunity to replicate and grow in a nutrient rich 
environment (Lamont, Chan et al. 1995). Although it is protected inside the host cell, it 
must still contend with the host cells defense mechanisms. One of these defenses, NO, 
is capable is diffusing through cell membranes and the invading bacteria must contend 
with the cells own NOS enzymes.  
1.3 Hemoproteins 
 A hemoprotein is a metalloprotein containing the heme prosthetic group. The 
heme prosthetic group is an organic compound that allows the protein to carry out a role 
that it cannot do alone. Heme is a cyclic molecule that consists of an iron atom 
coordinated by 4 pyrrole groups, linked by methine bridges, forming a planar, highly 
hydrophobic porphyrin ring. The iron can have up to six coordination bonds: 4 bonds are 
to nitrogens of the 4 pyrrole groups, 1 to the side chain of the hemoprotein (generally a 
His or a Cys), and 1 typically to a ligand. The most common heme used in biology is 
iron coordinated by protoporphyrin IX (PPIX). Although iron is by far the most used 
metal in heme, it is possible for protoporpyrin IX bind other cations. 
 Hemoproteins have a diverse set of biological functions, including diatomic gas 
transport (hemoglobin), chemical catalysis (peroxidases), diatomic gas sensor proteins 
(FixL), and electron transfer (cytochromes) (Wandersman, Stojiljkovic 2000). Different 
hemoproteins respond very differently to the presence of the same ligand despite 
having a common prosthetic group. The variation is due to different axial ligation by 
protein side chains and a variety of secondary interactions, such as H-bonding, with 
residues in the heme pocket. 
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1.3.1 The role of Heme in Porphyromonas gingivalis. 
 Heme is required for growth of Porphyromonas gingivalis (Schifferle, Shostad et 
al. 1996). Heme and iron play necessary roles in the oxidative stress response (Henry, 
McKenzie et al. 2012), nitrosative stress response (Lewis, Yanamandra et al. 2012), 
and metabolism.  Although it is a necessary component of many biological processes in 
the bacterium, it lacks the necessary mechanisms to synthesize the porphyrin ring. 
Furthermore, the concentration of iron, a necessary nutrient for almost all living 
organisms, in vivo is too low to support microbial growth. To rectify this problem P. 
gingivalis turns to scavenging iron and heme using various methods including 
proteolytic degradation.    
1.3.2 Heme acquisition and uptake mechanisms 
 When heme is not readily available, the bacterium turns to other methods to 
obtain the valuable cofactor. The bacterium expresses gingipains which are a family of 
proteases/hemagglutinin complexes. The hemagglutinins have an active role in 
adhesion to and hemolysis of erythrocytes and constitutively have Arg or Lys protease 
activity. In addition to the protease-associated hemagglutinins, P. gingivalis can express 
a number of other proteins that are capable of adhering to erythrocytes. Once they are 
bound to the erythrocyte, hemolysins disrupt the cell causing the release of hemoglobin 
or other hemoproteins. The protease activity degrades the hemoglobin or other heme 
carrriers, leading to the release of free heme (Lewis 2010).  
 After it has been released, the heme must be transported into the cell. P. 
gingivalis encodes for 3 different heme uptake mechanisms: ihtABCDE, Tlr, and hmu. 
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(Fig. 4) ihtABCDE codes fo an iron-heme transport made up of 5 different protiens 
encoded by a single operon. Tlr is a Ton-B linked receptor that is similar to the iht 
encoded binding system, however it has a putative ATP-binding cassette for heme 
transport. The third transport, enconded by hmu operon, has recently been identified 
(Lewis 2010). Although they are vital to the survival and pathogenesis of P. gingivalis, 
the specific mechanisms used by the heme transport systems are not clear and being 
researched extensively. 
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1.4 NO and its role and biology 
 Nitric Oxide (NO) is a signaling and defense molecule in eukaryotic organisms. It 
is most notable for its role in the regulation of vasodilation in the cardiovascular system 
(1998 Nobel Prize in Physiology and Medicine) and its secretion by the immune system 
as a means to combat bacterial infection.  NO is a free radical and can stabilize its 
unpaired electron two ways: reaction with species containing other unpaired electrons 
and interaction with the d-orbitals of transition metals, such as iron. In its reaction with 
iron, NO can form a rapid, stable, high affinity coordination bond with a ferrous iron in a 
heme group.  
 NO is uncharged and highly soluble in hydrophobic environments – a 
characteristic that allows it to freely diffuse through biological membranes. This not only 
makes it an excellent signaling molecule but a potent antimicrobial agent (Lancaster 
1997). 
1.4.1 Nitrosative stress and sources of nitrosative stress 
 Despite being a radical, NO is quite stable in biological environments depending 
on the components of the solvent and the concentration of oxygen (despite the common 
misconception that all free radicals are unstable and highly reactive) (Kroncke, Fehsel 
et al. 1997).  Reactive nitrogen species act in conjunction with reactive oxygen species 
to damage cells. NO will react very quickly with other free radicals (Fig. 1). The reaction 
between superoxide and NO forms peroxynitrite, a very reactive, powerful oxidant that 
can damage proteins, lipids and DNA.  It has been reported that the rate constant for 
the reaction of NO and O2- approaches the diffusion limit (Hill, Dranka et al. 2010, 
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Koppenol 2001). NO will react with most ROS, forming highly reactive products (Fig. 5). 
Ultimately, peroxynitrite is capable of degrading the very reactive and highly toxic 
hydroxyl radical (Fig. 1).  
 NO will also react with O2 to form nitrite, nitrate, and nitrous anhydride. The 
intercom-version of these compounds can also be catalyzed by bacterial sources, of 
which NO is an obligate step. (Fig. 2). When we eat a meal, bacteria in our mouth and 
gut can produce nitrogen species as metabolic byproducts from nitrates present in our 
diet. Although not as reactive as peroxynitrite, high concentrations of nitrites and 
nitrates can be a source of nitrosative stress to hosts and bacteria. NO is capable of 
reacting with ammonia to stimulate the creation of hydroxylamine. Hydroxylamine is 
common mutagenic species that is capable of causing base-pair point mutation, and 
must be cleared.  
 NO is also synthesized by eukaryotic cells through the action of NO synthases or 
NOS enzyme. NOS enzymes catalyze the NADPH and O2 dependent oxidation of 
arginine to citrulline and NO. The enzymatic synthesis of NO by the enzymes is 
complex and is dependent on many prosthetic groups and cofactors (Alderton, Cooper 
et al. 2001). Two types of NOS are relevant to bacterial infection: 
(1) – eNOS (NOS3) – generates low levels of NO and is found in endothelial and 
epithelial cells among other cells types (such as cardiac myocytes and 
neurons)(Dudzinski, Michel 2007). 
(2) – iNOS (NOS2) –  inducible, generates the highest level of NO and is found in 
cells of the immune system that stimulate the inflammatory response (Kone, 
Kuncewicz et al. 2003). 
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Figure 1 – Reactive Nitrogen and Reactive Oxygen species  
Reactive nitrogen and oxygen species are dynamic, constantly changing and reacting 
based on the environment. This chart is mainly focused on reactive nitrogen species 
that can be harmful to bacteria.  
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Figure 2 – The bacterial Inorganic Nitrogen Cycle Image adapted from Rodionov, D. 
A., Dubchak, I. L., Arkin, A. P., Alm, E. J., & Gelfand, M. S. (2005). Dissimilatory 
metabolism of nitrogen oxides in bacteria: Comparative reconstruction of transcriptional 
networks PLoS Computational Biology, 1(5).  
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1.4.2 Nitrosative Stress response 
 Bacterial cells must develop methods to protect cellular components from 
damage to reactive nitrogen species. Nitrosative stress responses detect increased 
concentrations of reactive nitrogen species and modulate the expression of necessary 
genes to clear the toxic species, usually through enzymatic means (Fang 2004). 
Several enzymes have been implicated in the detoxification of RNS in microbial 
species: microbial hemoglobins, nitrous oxide reductases, hydroxylamine reductases, 
and peroxynitrite reductases (Pathania, Navani et al. 2002, Gardner, Helmick et al. 
2002, Bryk, Griffin et al. 2000, Boutrin, Wang et al. 2012). Furthermore, these 
antioxidant methods are required for infection in certain species.  
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1.5 Transcription factors and the regulation of stress responses in bacterial cells 
 Proper regulation of transcription is a necessity for all living cells. For a single cell 
organism it must be highly responsive due to how quickly the environment can change. 
Transcription factors are regulatory proteins that bind to a specific sequence of DNA, 
thereby controlling the expression of a gene at the transcriptional level. Transcription 
factors can promote, repress, or actively recruit RNA polymerase to an operon 
(Latchman 1997). A characteristic feature of transcription factors is the presence of a 
DNA binding domain that is specific for a sequence of DNA. This domain allows the 
protein to augment the flow of gene expression by binding directly to DNA (Ptashne, 
Gann 1997). The activities of many transcription factors are directly regulated by binding 
of a signal cytoplasmically or indirectly regulated by binding of extracellular proteins and 
peptides to cell-surface receptors. Structural analysis of many prokaryotic transcription 
factors has revealed that most are homo-dimers that bind to palindromic DNA sites 
(Huffman, Brennan 2002). Transcription factors regulate cell development, growth, 
differentiation, and coordinate stress responses. There are many transcription factors 
that are divided into families according to their DNA binding motif (helix-turn-helix, zinc 
finger), cofactor binding, and role (Pabo, Sauer 1992). 
1.5.1 Transcription factors and stress response 
 Stress is a fact of life for bacterial cells. The environment which they inhabit can 
rapidly switch from good to bad: the pH may shift suddenly or nitrosative/oxidative 
stress may abruptly appear. Thus bacteria are constantly subjected to sources of 
potential stress. To cope, they must quickly express the necessary stress response 
genes and modulate expression of unnecessary genes. Many prokaryotic cells express 
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transcription factors that serve as sensor molecules. These proteins are activated 
indirectly (through the function of a membrane protein) or directly (direct binding of a 
metabolite or toxic molecule to the protein) and quickly change protein expression using 
their DNA binding domains. OxyR is a redox sensor in E. coli and many other microbes 
(Zheng, Storz 2000). The OxyR protein contains a thiol-disulfide redox switch to sense 
the presence of hydrogen peroxide allowing rapid activation of the protein. Once 
activated, the protein binds to specific palindromic sequences that are located upstream 
of the peroxidase and other antioxidant stress genes. Transcriptional activation then 
occurs through direct contact between OxyR and RNA polymerase (Zheng 1998). 
Although not all sensors/transcription factors follow this strategy, they all must employ a 
mechanism that allows for a rapid response to a change in the environment.  
1.5.2 Hemoproteins as sensor proteins.  
The ability of an organism to sense and respond to its environment is of utmost 
importance to its survival. Sensor proteins allow for physiological responses to 
environmental stimuli on a cellular level. Stimuli can include hypoxia, hyperoxia, or the 
presence of signaling molecules. A wide range of sensor proteins exists, many of which 
carry a cofactor. Over the years a wide and rapidly increasing range of heme-based 
sensor proteins have been discovered (Liebl, Lambry et al. 2013). 
Heme proteins are nature’s receptors for the gaseous CO, NO, and O2 
molecules. These gaseous XO molecules play important roles in many biological 
processes such as signaling and metabolism. The heme prosthetic group acts as a 
binding platform for the diatomic gases, performing a role that protein could not do on its 
own. By binding to the heme, the XO molecules can trigger a protein conformational 
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change that can initiate DNA binding or an enzymatic reaction and allow the organism 
to react in an appropriate manner. The surrounding protein and its side chains in the 
heme pocket are critical in determining the specificity among the gaseous XO molecules 
and for guiding the subsequent protein conformational change. Steric contacts can 
directly influence ligand binding and distort the porphyrin ring, influencing the Fe-XO 
binding properties (Spiro, Soldatova 2012, Spiro, Soldatova et al. 2013).         
 In principle, heme based gas sensors act as bi-stable switch proteins. The 
switching from one state to the other is initiated by binding of the gaseous XO ligand to, 
or dissociation from, the heme (Fig. 3). The switching from an inactive to an active state 
are well-defined biochemical events that intrinsically take place on the timescale of bond 
vibrations (Liebl, Lambry et al. 2013). 
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Figure 3 - General scheme of inter-protein signal transition of a heme sensor 
Image adapted from Liebl, U. et al, 2013. Primary processes in heme-based sensor 
proteins. Biochimica et Biophysica Acta (BBA) - Proteins and Proteomics. 1834: 1684-
1692. Heme sensor proteins are bistable switch proteins. Binding of ligand, such as NO, 
induces a conformational change in the protein, promoting the active state. The 
conformational change occurs on the order of bond vibrations. The protein performs a 
role while active. Loss of the ligand binding causes the protein to revert to the inactive 
state.  
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1.6 Nitrosative Stress and Porphyromonas gingivalis 
 There are multiple sources of nitrosave stress in the oral cavity. Nitrite 
concentrations can range from 10 μM to more than 1 mM (Lundberg, Weitzberg et al. 
2004). Nitrite is produced by oral bacteria as a byproduct of metabolism and dietary 
intake of nitrate and nitrite rich foods is the main source of reactive nitrogen species in 
the oral cavity. Nitric oxide may be generated by nitrite in the oral cavity through the 
bacterial respiratory nitrite reductase system NrfHA (Spiro 2006, Hammes 2012) (Fig. 
2). Intake of food that lowers the pH of the oral cavity creates favorable conditions for 
the conversion of nitrite to nitric oxide (Palmerini, Palombari et al. 2003). The innate 
immune system incorporates mass NO production as part of its response to bacterial 
infection. Bacterial invasion of endothelial cells causes an increase in NO production by 
their type 3 NOS enzymes. To survive in the periodontal pocket, P. gingivalis must have 
mechanisms to circumvent nitrosative stress from multiple sources.   
 The nitrosative stress response in P. gingivalis remains poorly understood. 
Recently, it has been shown that an Hcp (hybrid complex protein) plays a significant 
role nitrosative stress resistance (Boutrin, Wang et al. 2012). Hcp is a putative 
hydroxylamine reductase that is expressed during conditions of nitrite and nitrate stress 
and has been shown to be up-regulated in high concentrations of NO. Hcp has been 
extensively studied in other anaerobic and facultative anaerobic bacteria (van den Berg, 
Hagen et al. 2000, Beliaev, Thompson et al. 2002).  Hydroxylamine is a toxic byproduct 
that can be created during nitrite ammonification. Nitric oxide catalyzes the reduction of 
ammonia yielding hydroxylamine.  Hcp detoxifies hydroxylamine by converting it to 
water and ammonia.  
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1.6.1 HcpR’s role in the nitrosative stress response in Porphyromonas gingivalis  
 The response to nitrosative stress is regulated by FNR (fumarate-nitrate 
regulator) and FNR-like proteins in many bacteria, including E. coli. These regulators 
are structurally related to cyclic AMP receptor protein (CRP) and fumarate and nitrate 
reduction regulator (FNR) from E. coli (Schultz, Shields et al. 1991, Spiro 1994). All 
members of this family are homo-dimers that are composed of 3 domains: a sensing 
domain that typically utilizes an iron-sulfur cluster, a dimerization helix, and a DNA 
binding domain. The members of this family control many important pathways in a wide 
variety of bacterial species; these include (but not limited to) hypoxia, oxygen exposure, 
oxidative stress and nitrosative stress. HcpR is a novel FNR-like regulator that is 
predicted to regulate the expression of hcp and other genes responsible for 
denitrification. It lacks the conserved cysteine residues required for binding of the Fe-S 
cluster seen in FNR and its homologues. HcpR has been shown to control the 
expression of Hcp in the Desulfovibrio species of anaerobic bacteria and is proposed to 
be present in many other bacterial species such as Baccteroidetes, Geobacter, and 
Thermotogales (Rodionov, Dubchak et al. 2004, Arai, Mizutani et al. 2003, Cadby, 
Busby et al. 2011).  
  HcpR is believed to help coordinate the nitrosative stress response in P. 
gingivalis. Under conditions of NO or nitrite stress hcp, a putative hydroxylamine 
reductase, (PG0893) has been shown to be up-regulated (Boutrin, Wang et al. 2012). 
HcpR has been shown to bind directly to the hcp promoter. Knockout of the putative 
HcpR gene (PG1053) in P. gingivalis W83 nullifies the up-regulation of Hcp under 
conditions of nitrosative stress. Furthermore, growth of the knockout strain was greatly 
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reduced in the presence of nitrite and NO and did not survive with host cells, revealing 
that HcpR plays a vital role in the virulence of P. gingivalis. The nitrosative stress 
response was also shown to be dependent on heme, implying that heme may play a 
role in detoxification or recognition of the diatomic gas molecule NO. Up-regulation of 
the major heme uptake gene hmuY (PG1553) was seen in the presence of NO 
generating agents. Furthermore, hemin is required for binding of recombinant-HcpR to 
the hcp promoter (Lewis, Yanamandra et al. 2012). Bioinformatics studies of the gene 
product of P. gingivalis-HcpR reveal that it is related to DNR, an FNR like transcription 
factor that plays a role in the nitrosative stress response in Pseudomonas aeruginosa 
(Giardina, Rinaldo et al. 2009, Castiglione, Rinaldo et al. 2009). 
 DNR is a member of the FNR superfamily of transcription factors. It is a sensor 
protein that lacks the conserved cysteine residues necessary to form the Fe-S cluster; 
instead it utilizes the heme cofactor to bind the diatomic gas molecule NO. It is 
theorized that direct binding of NO stimulates the activation of the protein allowing it to 
modulate expression of genes responsible for denitrification, although the exact 
mechanism of activation is not understood (Castiglione, Rinaldo et al. 2009). HcpR 
appears to play a similar role in P. gingivalis. The exact mechanisms that govern the 
nitrosative stress response in P. gingivalis are not understood even though they are 
important aspect of the micro-organism’s survival and virulence.  
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Chapter 2 – Hypothesis and Aims 
2.1 Hypothesis 
HcpR is a sensor transcription factor that is a vital part of the nitrosative stress 
response in P. gingivalis. HcpR is a homodimer, heme binding protein that utilizes the 
heme-bound iron to bind the diatomic gas molecule NO, a reactive nitrogen species and 
one of the causative agents of nitrosative stress in mouth and periodontal pocket. 
Binding of NO to HcpR bound heme causes a change in the oxidation of Iron(III) to 
Iron(II) producing a conformational change of the protein that allows the protein to 
modulate expression of genes at a promoter upstream of a target gene.   
2.2 Aims 
The main goal of this project is to characterize HcpR and better understand the 
mechanisms it uses to regulate the nitrosative stress response in Porphyromonas 
gingivalis. The following specific aims have been performed to attain this goal: 
Aim 1: Use bioinformatics resources to construct a molecular homology model and 
analyze the primary sequence of HcpR. Bioinformatics is a good starting point, and we 
will use a number of bioinformatics resources at our disposal to understand the 
structure and function of the protein.  
Aim 2: Determine the oligomeric state of HcpR. Most prokaryotic transcription factors 
are dimers in solution. Understanding the stoichiometry of the protein is necessary for a 
basic understanding of its behavior.  
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Aim 3: Analyze the heme binding properties of HcpR. Predictions suggest that HcpR 
belongs to a class of regulators that utilize heme as a sensor for nitrosative stress. UV-
Vis spectroscopy, CD spectroscopy, TMBZ assays, and Fluorescence assays will be 
used to analyze the heme binding properties. 
Aim 4: Analyze the NO binding properties of HcpR. To be an efficient regulator, the 
protein must bind a ligand to stimulate a response. Anaerobic UV-Vis spectroscopy and 
Resonance Raman spectroscopy will be used to analyze the NO binding properties. 
Aim 5: Analyze the structure of HcpR. To fully understand the mechanisms of HcpR, 
information on the structure must be obtained. SAXS will be employed to gain some 
knowledge on the structure of HcpR. We will also attempt to crystallize HcpR and solve 
its structure.  
Aim 6: To further ascertain the biological significance of HcpR, the creation of a 
promoter assay will allow for the quantification of efficiency of the activation of HcpR.  
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Chapter 3 – Materials and Methods 
3.1 – Bioinformatics 
Using the protein Basic Local Alignment Search Tool (PBLAST) on the HcpR 
sequence, an FNR-like regulator in Pseudomonas aeruginosa  with a similar sequence 
was found (Lewis, Yanamandra et al. 2012); a partial crystal structure of DNR has been 
solved (PDB 3DKW). Using DNR as a template and the one-to-one threading method of 
Phyre protein folding server (Kelley, Sternberg 2009), a 3-Dimensional homology model 
of HcpR was constructed. Chain A of DNR was used as a template, and dimer 
homology model was made by using the match-maker function in UCSF chimera using 
DNR chains A and B as a template (Pettersen, Goddard et al. 2004). InterproScan5 was 
used to match the sequence of HcpR against a number of databases to predict 
conserved domains of the protein (Jones, Binns et al. 2014).  
3.2 – Cloning and Expression 
The sequence of the HcpR gene (PG1053) was identified in the Oralgen W83 
Porphyromonas gingivalis genome database (oralgen.org). Primers were designed and 
the hcpR gene was PCR amplified from W83 P. gingivalis genomic DNA. Three vectors 
were chosen for expression: the pFC20K HaloTag T7 SP6 flexi vector (Promega 
Corporation), pET30-A and a modified pET21-A vector (provided by Dr. Peterson). The 
primers for cloning into the pFC20K vector were engineered to have SgfI (forward) and 
EcoICRI (reverse) restrictions sites (Table I). The primers for cloning into the m-pET21 
vector were engineered to have BamHI (forward) and XhoI (reverse) restriction sites 
and amplified the full length gene (Table I).  
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The DNA amplified with the m-pET primers was cloned into the m-pET21d vector 
to create m-pET21-hcpR. The PCR product and vector were digested with BamHI and 
XhoI and gel purified. The digested fragments were ligated with T4 DNA ligase (Life 
Technologies) and transformed into TOP10 cells (Life Technologeis) for antibiotic 
resistance screening. A successful clone was identified and sequenced. The clone was 
engineered to have a tail of six histidines attached to the carboxy terminus of the gene 
product. The m-pET21d sequence contains a TEV protease cleavage site between the 
end of the hcpR gene sequence and the His tag. This cleavage site was used to remove 
the His tag after purification.  
The DNA amplified with the HcpR-halo primers was cloned into the pFC20K 
vector to create Halo-hcpR. The PCR product was digested with SgfI and EcoICRI; the 
vector was digested with SgfI and PmeI. The fragments were gel purified and ligated 
using T4 DNA ligase. The ligation product was transformed into DH5-alpha competent 
E. coli (Bioline) for antibiotic resistance screening. A successful clone was identified and 
sequenced. The clone was engineered to place the Halo tag sequence at the carboxy 
terminus of the gene product. The Halo tag is an 890 b.p. region that codes for an 
antibody binding domain which is used for immunoprecipitation; between the Halo tag 
and 3’ end of the wt-hcpR there is a TEV cleavage site used to remove the tag from the 
protein.   
Cloning and production of the pET30-hcpr plasmid are detailed in Lewis, 
Yanamandra et al. 2012. 
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Table I – Primers used in this Study 
 
 
 
 
 
 
 
 
 
m-pET-hcpR-Forward CTTCCAGGGATCCCCAGAATTCGATCTTC 
m-pET-hcpR-Reverse GCGCACTCGAGTTACTCCAGCCTCGACA 
Halo-hcpR-Forward TTGTGTTTAAACCTCCAGCCTCGACAA 
Halo-hcpR-Reverse GCCGGCGATCGCCATGGATCCCGAAT 
pACYc-184-hcpr-Forward CCGTCACCCAGGATGCTGTAGATGGATCCCGAATTCGATCTTC 
pACYc-184-hcpr-Reverse CCATCCAGCCTCGGGTCGCGATTACTCCAGCCTCGACAATC 
pACYc-Sequencing-F TGAAGTCAGCCCCATACGAT 
pACYc-Sequencing-R GGCATAAATCGCCGTGAC 
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Table 2 – Vectors used in this study 
pET30-hcpR pET30 vector with hcpR insert. Contains 
a Strep tag and His-Tag on the N-terminal 
region. 
 
m-pET21-hcpR Modified pET21 vector with HcpR insert. 
The vector removes N-terminal S-Tag 
and adds a TEV site to cut off C-termianl 
6x His tag 
.  
Halo-hcpR  pFC20K with the HcpR insert. Adds a 
halo antibody tag on the C terminal region 
for immunoprecipitatio. TEV site used to 
remove tag. 
  
PACYc-184-hcpR PACYc-184 vector with hcpR insert used 
for promoter studies.. A low copy vector 
at roughly ~15 copies per cell.  
 
PUC57 A high copy vector that contains the 
promoter constructs used for the 
promoter studies. 
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The m-pET21-hcpR and pET30-hcpR plasmids were transformed into BL21 
(DE3) E. coli (Bioline) for expression. The Halo-hcpR plasmid was placed into KRX E. 
coli (Promega) for expression.  
The m-pET21-hcpR and pET30-hcpR in BL21 (DE3) were grown in Luria-Bertani 
(LB) broth or self-induction media (recipe in appendix) with shaking (225 RPM) at 37 °C. 
At mid log phase (~0.6 OD at 660 nm) the LB cultures were induced with a final 
concentration of 1 mM IPTG and grown overnight. The self-induction media cultures 
were grown overnight with shaking (225 RPM) at 37°C. The Halo-hcpR in KRX E. coli 
was grown in LB broth with shaking (225 RPM) at 37 °C. At mid log phase the culture 
was induced with a final concentration of 0.008% of L-rhamnose and grown overnight.  
3.3 Purification of HcpR 
3.3.1 His-tag Purification 
After growth and induction the cells were spun down at 12,000 RCF and washed 
with PBS. Cell pellets were suspended in binding buffer (50 mM NaH2PO4, 300 mM 
NaCl, 10 mM imidazole, pH 8.0) and 100 mg of Lysozyme was added. The lysis solution 
was incubated on ice for 30 minutes. After incubation the cells were sonicated.  The cell 
lysates were centrifuged at 15000 RPM to pellet cell/cell debris. The lysates were 
passed through a column containing a Ni-NTA Resin (Qiagen) equilibrated with binding 
buffer. The column was washed with 200 mL of wash buffer (50 mM NaH2PO4, 300 mM 
NaCl, 25 mM imidazole, pH 8.0). The protein was eluted from the column with 250 mM 
imidazole solution. The elutions were run on a 10% SDS-PAGE gel to check for purity.  
Elutions were dialyzed to remove excess imidazole and tag was cut off the 
purified HcpR using TEV protease (kindly supplied by Dr. Peterson) at room 
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temperature. The completeness of the TEV cleavage was monitored using SDS-PAGE 
gels. Once cleavage was complete, the purified protein was applied to the Ni-NTA 
column and incubated with the resin for 15 minutes, before eluting the untagged, 
purified HcpR. The purified protein was stored at -80 ºC. 
3.3.2 Halo-tag Purification 
 Induced cell cultures were spun down and suspended in purification buffer (50 mM 
Hepes, 150 mM NaCl, 1 mM DTT, pH 7.0). Cells were lysed using cell-lytic B reagent lysis 
reagent (Sigma-Aldrich). To each sample, 10 units of benzonase (Sigma-Aldrich) were 
added to degrade genomic DNA. The cell debris was spun down and the cell lysate was 
added to Halo-link resin (Promega). The cell lysates were incubated with the resin for 1 
hour at room temperature with inversion. After incubation, the sample was washed with 50 
mL purification buffer via batch method: samples were spun down and supernatant 
removed and 10 mL of buffer added.  HcpR was eluted from the resin by adding TEV 
protease to the resin and inverting at 4°C overnight. Elutions were analyzed on SDS-PAGE 
gels. The purified protein was then stored at -80°C.  
3.3.3 Reconstitution of purified HcpR with Heme 
 Purified HcpR was reconstituted with 1.5 molar excess of heme in 0.1 M NaOH. The 
mixture was incubated for 30 minutes - 1 hour at room temperature. Dialysis was used to 
remove excess heme and salt. 
3.4 Native Gel electrophoresis 
 Native gel electrophoresis was done using the recombinant protein purified from E. 
coli cntaining pET30-hcpR. The sample protein was not de-tagged. A Tris-Acetate 
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polyacrylamide gel was run in 50 mM Tris-Glycine buffer for approximately 2 hours. Apo, 
Heme, and DNA-complex HcpR were run at varying amounts.   
3.5 Analytical Ultracentrifugation 
HcpR was purified using the Halo method as described before and dialyzed into 50 
mM Hepes, 150 mM NaCl, and 1 mM DTT. Apo HcpR was diluted into 4 different 
concentrations: 0.1 mg/ml (2.0 µM), 0.2 mg/ml (3.9 µM), 0.5 mg/ml (9.8 µM) and 1.0 mg/ml 
(19.6 µM).  A Beckman Optima XL-I analytical ultracentrifuge was used to analyze the 
samples. The velocity sedimentation experiment was run at 4000, 5000, and 7000 RPM 
in a four-position AN-60Ti rotor at 20°C in aluminum double sector cells. Concentration 
profiles were recorded using UV absorption (280 nm and 260 nm).  
3.6 TMBZ assay 
To test for the presence of heme binding to HcpR, 15 μg of reconstituted HcpR 
was run on a native 10% polyacrylamide gel. Hemoglobin was used as a positive 
control and P. gingivalis OxyR was used as a negative control. The gel was run for 
approximately 1 hour in 50 mM Tris-Glycine running buffer. After running, the gel was 
soaked in TMBZ (tetramethylbenzidine) for 30 minutes. The TMBZ was poured off and 
the gel cleaned with water. Hydrogen peroxide (3%) was then applied to the gel. The 
presence of heme was marked by a blue-green stain.  
3.7 UV-Vis studies 
Heme was titrated with varying dilutions of purified apo HcpR (Fig. 16) to observe 
spontaneous binding to HcpR. Sample buffer was 25 mM Phosphate, 100 mM NaCl at 
pH 7.0. The samples were scanned from 200-800 nm using a Thermo Biomate 3S UV-
Vis spectrophotometer.  To study anaerobic effects of heme binding Apo-HcpR was 
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made anaerobic by placing in an anaerobic atmosphere chamber. Anaerobic heme 
solution was added to the sample in a 1:1 ratio and the sample was scanned from 200-
800 nm in a sealed quartz cuvette. 
Reconstituted HcpR was dialyzed into 25 mM Phosphate, 100 mM NaCl, and 1 mM 
TCEP.  The samples were placed in an anaerobic chamber and 10 mM Dithionite was 
added to the samples. The samples were incubated overnight in the chamber then passed 
through a PD-10 desalting column (GE healthcare) to remove excess dithionite. NONOate 
was used to prepare nitrosylated samples. 20 mg of NONOate was dissolved in 100 μL 
buffer and NO formation was observed by the formation of bubbles in solution. Nitrosylated 
samples were prepared by adding 50 μL of dissolved NONOate to 450 μL of 1 mg/mL HcpR 
sample. Samples were placed in sealed quartz cuvettes to maintain integrity of the 
anaerobic samples and scanned from 280-800 nm. 
3.8 Fluorescence Studies  
To test for heme binding a time scan titration was performed using heme to titrate 
HcpR. A 1 mg/ml sample of Apo-HcpR was titrated with 20 μL of 1 mg/ml solution of 
heme. The sample was excited at 280 and the emission was monitored from 300 to 
460.  
To better understand the binding properties, a standard curve was constructed to 
define the binding parameters. Purified HcpR was dialyzed into 25 mM Hepes, 100 mM 
NaCl, and 2 mM TCEP. A heme dilution series was constructed keeping HcpR constant 
at 6.667 μM. The samples were excited at 280 nm and emission was observed at 340 
nm.  A quartz cuvette was used for analysis in an ISS PC1 fluorimeter.  
3.9 CD Studies 
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Apo and Heme forms of HcpR at 0.5 mg/mL (9.8 µM) were used for CD studies over 
a spectrum of 170-260 nm wavelength. Buffer was 25mM Phosphate, 50 mM NaCl, pH 7.0. 
An Olis DSM 1000 CD spectrophotometer was used to collect the data in quartz cuvettes. 
All samples were collected at room temperature.  
Analysis of NO binding was done under anaerobic conditions. 5mM of dithionite was 
added to the heme-HcpR. The samples were nitrosylated by using 10 mg NONOate added 
directly to the sample. The cuvette was capped in an anaerobic chamber. Spectrum of both 
anaerobic nitrosylated and anaerobic non-nitrosylated samples were generated in 170-260 
nm range. All samples were collected at room temperature.  
 
3.10 Resonance Raman Studies 
HcpR was purified using the 6x His tag method as previously described and 
heme-reconstituted as previously described. The samples were dialyzed into purification 
buffer (25 mM Tris, 100 mM NaCl, and 2 mM TCEP at pH of 7.5) and concentrated 
down to 20 mg/ml (392 µM). 5 mM dithionite was added to the samples and then placed 
under anaerobic conditions overnight. After overnight anaerobic exchange, NONOate 
was used to nitrosylate samples. The samples were put in glass melting point capillaries 
under anaerobic conditions and sealed. The spectra were obtained with a krypton ion 
laser at 406.7 nm (Coherent Sabre DBW laser). The detection system used was a liquid 
N2 cooled 400 x 1340 CCD detector (Princeton Instruments, Roper Scientific, Trenton, 
NJ) and a 0.5 m spectrograph (Spex model 1870; Horiba/Jobin-Yvon, Edison, NJ) set to 
100 um slit width and fitted with an 1800 or 2400 L/mm holographic grating (Jobin-
Yvon). GRAMS/AI version 7.0 was used to perform spectral baseline leveling by a fifth 
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order polynomial routine. The mathematical peak fitting module of Origin Pro version 7.5 
was used to deconvolute band shapes and generate the spectral graph. 
 
3.11 Small Angle X-ray Scattering  
Recombinant HcpR was purified and sent to the SIBYLS beamline at the Lawrence 
Berkeley National Laboratory. A concentration gradient of 0.5 mg/ml, 1.0 mg/ml, and 2 
mg/ml of Apo and DNA-complex HcpR and 0.25 mg/ml, 0.5 mg/ml, and 1 mg/ml of the 
Heme-HcpR was exchanged in 25 mM Tris, 100 mM NaCl, and 2 mM TCEP at pH 7.5 
buffer.  Each form of the protein was dialyzed against 2 L of the buffer overnight before 
being sent off. The matching buffer was sent with it. The ATSAS package was used to 
analyze the scattering profiles and create the Kratky, Guinier, and distance-distribution 
function graphs. DAMMIF was used to create the ab initio models. The FoXS server was 
used to create a theoretical scattering curve of the HcpR homology model. 
3.12 Promoter Studies  
 The hcpR gene was cloned into the pACYC184 vector (New England Biolabs) under 
the constitutive tet promoter yielding the plasmid pACY-hcpR. The hcpR PCR product was 
engineered to add SfcI (5’-end) and NruI (3’-end) restriction sites (enzymes from NEB). 
Vector and PCR product were digested, gel purified, and ligated. Ligation product was 
transformed into TOP-10 E. coli (Life Technologies) for antibiotic resistance screening on 
chloramphenicol plates. A successful clone was identified and sequenced. Three reporter 
systems were created using the P-glow Bs2 gene. The Bs2 gene carries the DNA sequence 
of a truncated YtvA from the blue-light photoreceptor of Bacillus subtilis which is optimal for 
using in anaerobic conditions. It encodes only the photoactive LOV domain optimized for 
usage in E. coli. The molecular weight is 19 kDa and the protein forms homodimers in 
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solution. The Bs2 gene was placed downstream of the hcp promoter of Porphorymonas 
gingivalis creating the construct pUC-GLOW-PG. Two other constructs were created: the 
DNR binding site of the Pseudomonas aeruginosa nor promoter was replaced with the 
HcpR binding site and placed upstream of the Bs2 gene creating pUC-GLOW-PA; the FNR 
binding site of the E. coli melR promoter was replaced with the HcpR binding site and 
placed upstream of the Bs2 gene creating pUC-GLOW-EC. All 3 constructs were 
synthesized (Genescript) and placed into the pUC57 vector. The promoter-reporter 
recombinant genes were flanked with NdeI (5’ end) and BamHI (3’ end) restriction sites.  
 Each reporter construct was co-transformed into TOP-10 E. coli with the pACY-hcpr 
construct. Overnight cultures of each strain were used to inoculate 20 mL LB broth. Each 
culture was grown at 37°C with shaking (225 RPM) to OD660 0.5 and were placed in an 
anaerobic chamber. The cultures sat in anaerobic conditions for 30 minutes to remove 
oxygen. The cultures were distributed into a 96 well plate, and pipetted vigorously to 
remove residual oxygen. A gradient of an increasing amount of NONOate dissolved 
solution or nitrite was added to each well. After a 1 hour incubation, the cells were 
measured for the fluorescence via excitation at 450 nm and emission at 495 nm.  
3.13 Crystal Screening  
 A wide range of conditions were screened by hand to obtain a crystal of the 
native-HcpR using hanging drop vapor diffusion, sitting drop diffusion, and oil diffusion 
methods. A number of commercially available crystallization screens were employed: 
Crystal Screens 1 and 2 (Hampton Research), Natrix Screen (Hampton Research), 
Wizard Classic Crystallization screens 1, 2, and 3 (Rigaku reagents). Screens were 
placed at 20ºC, 16ºC, and 4ºC.  
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Figure 4 – Schematic overview of promoter study 
hcpR will be cloned into the pACY184 plasmid, a vector that has a low copy number 
(and thus a low expression). The pACYC-hcpR vector will be co-transformed into E. coli 
with a vector containing a fluorescent reporter gene downstream of the hcp promoter 
(vectors detailed in figure 5). The bacteria will be stimulated with reactive nitrogen 
species and the expression of the reporter gene will be quantified.  
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Figure 5 – Construct used in promoter studies 
There are 3 reporter constructs utilized in this study; each construct utilizes the BS2 
fluorescent reporter gene downstream of a promoter. Three promoters are used: the P. 
gingivalis hcp promoter; the P. aeruginosa nor promoter; the E. coli melR promoter. The 
DNR binding site was replaced in the nor promoter with an HcpR binding site and the 
FNR binding site in the melR promoter was replaced with an HcpR binding site.  
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Chapter 4 – Results 
4.1 Bioinformatics results 
 The Apo-HcpR homology model was based on the Apo-DNR crystal structure. 
DNR is a heme-binding sensor protein that regulates the nitrosative stress response in 
Pseudomonas aeruginosa. DNR oligomerizes as a dimer in solution, however the unit 
cell of the crystal structure is an octamer of 4 dimers (PDB 3DKW). Chain A of DNR and 
the HcpR homology model were over-layed using the match-maker function of Chimera: 
the RMSD between the homology model and DNR-chain A is 0.179 (Fig. 6-7). The low 
RMSD indicate a high structural similarity. Using the QMEAN server for homology 
model estimation, it should be noted that the energy levels for HcpR aren’t as low as 
DNR. This indicates that although it is a good match, there is some forced positioning. 
Most of the variation between the homology model and DNR is in the N-terminal DNA 
binding region.  
 The HcpR homology model is made up of 3 domains: an N-terminal Ligand 
Binding Domain, a dimerization helix, and a C-terminal DNA binding domain (Fig. 8). 
Residues 1-125 form the heme binding domain. The ligand binding domain forms a 
pocket structure that has a high number of hydrophobic residues, which are most likely 
needed for binding of the highly hydrophobic heme cofactor (Fig 9).  Residues 126-171 
forms the dimerization helix. The residues along the central helix form a high number of 
interactions, creating a tight bonding between the two subunits. Residues 172-228 
forms the DNA binding domain which contains a helix-turn-helix DNA binding motif. This 
specific motif is a common trait among members of the FNR-like superfamily.  
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 The InterProScan returned results that reaffirm the conclusions from the 
homology model (Fig. 10). The N-terminal region of HcpR resembles that of a Cyclic-
nucleotide binding domain; this is a common theme among members of the CRP-FNR 
superfamily. The C-terminal region of HcpR resembles a CRP helix-turn-helix DNA 
binding domain.    
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Figure 6 – Superimposed structures of HcpR and DNR 
All images generated using UCSF Chimera. The HcpR homology model (Blue) is over-
layed with DNR crystal structure (Red) (PDB: 3DKW) with an RMSD value of 0.179.  
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Figure 7 – Dimeric homology model of HcpR 
The model is a homo-dimer made up of two identical strands. The predicted homo-
dimer of HcpR was modeled after the crystal structure of the DNR homodimer.  
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Figure 8 – Domains of HcpR homology model 
The HcpR homology model (A) is made up of an N-terminal heme binding domain, a C-
terminal DNA binding domain, and a dimerization helix that links the two domains. The 
sequence of HcpR (B) is below and highlighted based on its domain. Text - Blue: N-
Terminal ligand binding domain; Green: dimerization helix; Red: C-temrinal DNA binding 
domain. 
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Figure 9 – Hydrophobic residues in the Heme binding pocket 
Hydrophobic residues in the postulated heme binding domain are highlighted in yellow. 
The protoporphoryin IX ring of heme is very hydrophobic, other heme binding proteins 
typically hold the cofactor through mainly hydrophobic interactions.  
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Figure 10 – InterProScan 4.8 Results 
InterProScan returns results from a number of databases that are used to scan the 
query sequence. The database used for each line is color coded with the legend at the 
bottom of the figure.  
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4.2 Expression and Purification of recombinant HcpR 
 A purified recombinant HcpR with or without the 6x-His tag appears as a 
monomer or dimer on SDS-PAGE gel. The purification method yields a pure (≥95%), 
mono-disperse protein solution in all buffers used. When reducing agents are added to 
the gel loading sample nearly all of the sample exists as a monomer. The presence of a 
cysteine residue (C33) allows for disulfide bond formation. Treatment with TEV protease 
yields de-tagged HcpR, which has an apparent molecular weight of approximately 20-25 
kDa.  
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Figure 11 – SDS-PAGE gel of purified HcpR 
Purified HcpR run on a 10% SDS-PAGE gel. The uncut lane (1) is run without reducing 
agents. After treatment with TEV protease (2-4) there is a noticeable reduction in the 
size of the protein.  
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4.3 Molecular Weight Calculation 
 Initial molecular weight estimation using purified recombinant tagged-HcpR from 
the pET30-hcpR E. coli on a native gel yielded a molecular weight estimation of 
approximately 100 kDa. This result was reinforced by SAXS studies and column 
chromatography using the pET30 HcpR. This would have distinguished HcpR from 
other FNR-CRP like regulators (and most prokaryotic regulators for that matter), 
however all of these experiments were carried out with a large Strep/His tag on the N-
terminus of the protein from the pET30 vector. Attempts to remove the tag using 
enterokinase were unsuccessful forcing us to use an alternative purification method. 
The Halo-hcpR was expressed in the KRX E. coli strain and the protein was purified 
through immunoprecipitation and the tag removed via TEV protease digestion. 
Analytical centrifugation of the de-tagged HcpR confirmed that it exists in solution as 
approximately 45-50 kDa dimer (Fig. 13). This result is confirmed through column 
chromatography and SAXS studies of the de-tagged m-pET21-hcpR protein. De-tagged 
HcpR natively forms dimers just as other members of the FNR-CRP superfamily.  
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Figure 12 – Native Gel of pET30-HcpR protein 
A Tris-Acetate native PAGE gel was used to estimate the size of the protein. Apo-HcpR 
(lanes 1-3), heme-HcpR (lanes 5-7), and DNA-HcpR (lanes 9-10) were run in varied 
concentrations. HcpR appears to be approximately 100 kDa in size in all forms of the 
protein.  
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Figure 13 – Sedimentation velocity experiment of tag-less HcpR protein 
Absorbance profile of the velocity experiment shows HcpR in solution as a ~48 kDa 
dimer. Four different concentration were used: 0.1, 0.2, 0.5, and 1.0 mg/ml. Buffer: 50 
mM phosphate buffer, 150 mM NaCl, 1mM DTT.  
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4.4 Analysis of Heme binding 
 The TMBZ assay is simply a shift assay for heme and was used to initially 
assess the heme binding properties of HcpR (Fig. 14). Reconstituted HcpR (lane 2) was 
run on a native gel with positive (hemoglobin – lane 3) and negative (OxyR – lane 1) 
controls. After the gel ran for approximately 30 minutes it was washed and incubated 
with TMBZ for 15-30 minutes. The TMBZ is soaked into the gel and excess TMBZ is 
washed off after incubation. After washing 3% hydrogen peroxide was sprayed onto the 
gel. Heme has a pseudo-peroxidase activity and TMBZ is chromogenic reagent used for 
peroxidase detection. In the presence of peroxidase/hydrogen peroxide the colorless 
TMBZ will complex and form a greenish blue color. This color only forms in the regions 
where the heme is located. Excess heme runs to the bottom of the gel and there is a 
greenish stain in the middle of the gel where heme is bound to protein. This assay is not 
positive under denaturing conditions, HcpR must folded in a native stave to bind heme.  
 Circular Diochroism was used to analyze heme binding effects on secondary 
structure (Fig 15). With the addition of heme, there is a change in the elipticity of the 
sample. This corresponds to a change in the secondary structure of the protein when 
hemin binds. Although the addition of heme does not yield a drastic change in 
secondary structure, there is a small yet reproducible change in what appears to be the 
alpha helical nature of the protein. 
 The heme binding properties of HcpR were further investigated by quenching of 
intrinsic tryptophan fluorescence (Fig. 16).The postulated heme binding domain of HcpR 
has one of two tryptophan residues (W12) found in HcpR. A fluorescence time scan 
titration was utilized to observe the effect of heme binding in real time. Titration of heme 
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into Apo-HcpR resulted in a dose-dependent progressive and saturable quenching of 
the tryptophan fluorescence. The loss of fluorescence intensity corresponds with the 
addition of heme to the cuvette. A binding event occurs when heme accesses the 
binding pocket and this binding event causes quenching of the tryptophan residue 
(whether this is due to direct interaction between heme and tryptophan or the exposure 
tryptophan side chain to solvent is not known). This change in fluorescence intensity 
corresponds with binding of ligand, and will allow us to possibly ascertain the binding 
parameters.  
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Figure 14 – TMBZ assay for heme binding  
Lane 1: Negative control (P.g.OxyR); Lane 2: HcpR; Lane 3: Positive control 
(hemoglobin). Samples were run on a 12% Tris-Acetate native gel.  
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Figure 15 – CD spectra of Apo- and Heme-HcpR under  
Dark: Apo-HcpR at 0.15 mg/mL   Light: Heme-HcpR at 0.15 mg/mL.  
 Heme binding assayed using CD spectroscopy. Binding of heme causes a reproducible 
shift in the elipticity caused by a change in the secondary structure.  
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Figure 16 – Heme Time scan titration of HcpR 
HcpR was titrated 4 times with 5 μg of heme to a 5 mM solution and excited at 280 nm. 
A time scan titration of the mixture over a spectrum of 300-460 nm. After the addition of 
heme to the sample there is a noticeable and reproducible decrease in the fluorescence 
intensity.   
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 The UV-Vis spectrum of HcpR-heme dilution series under aerobic conditions is 
shown in Figure 17. There appears to be no dose dependent change in the spectrum 
due to heme binding. This is unexpected as most heme binding proteins will show a 
change in the soret region (~400 nm) upon addition of heme to the binding site. No 
soret peak appears in any concentration. This issue is resolved when addition of heme 
is done under anaerobic conditions (Fig. 18). As can be clearly seen, a very sharp soret 
peak appears at 394 nm when the heme is added under anaerobic conditions. This 
effect is reproducible and is seen in the NO binding studies also.  
  To further quantify the heme binding properties of HcpR, a dilution series of 
heme was measured for their intensities, while keeping the concentration of HcpR 
constant (Table 3). The data points were used to construct a binding curve, from which 
the Kd can be approximated (Fig. 19). The result yielded a value of Kd = 155.6 µM. This 
value is extremely high and indicates relatively weak binding of heme to HcpR. 
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Figure 17 – Affinity of HcpR for heme under aerobic conditions 
The affinity of HcpR for heme was tested using UV-Vis spectroscopy. All experiments 
were done aerobically. Different molar ratios were tested and binding was monitored 
over a range of 280-500 nm. There seems to be no change in the morphology of the 
spectrum due to changes in the protein concentration. However, there is an increase in 
the absorbance due to the increase of protein concentration.   
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Figure 18 – UV-Vis spectrum of Heme binding under anaerobic conditions 
Heme (Fe2+) binding was analyzed under anaerobic conditions. A 1:1 ratio of heme to 
HcpR forms a large Soret peak at 398 nm.  
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Table 3 – Measurement of Heme to HcpR binding through intrinsic HcpR 
fluorescence quenching.   
HcpR concentration was held constant at 6.667 µM and heme titrated from 0 μM – 542 
μM heme. The intrinsic fluorescence intensity of HcpR was measured. Sample was 
excited at 280 nm and emission was measured at 340 nm.  
 
  Heme Concentration    Relative Intensity 
0 µM  130.1341 
28µM 105.4234 
40µM 92.93639 
76 µM 86.01876 
112 µM 81.88692 
148 µM 69.70366 
170 µM 65.19112 
222 µM 53.59291 
364 µM 22.22325 
470 µM 15.37927 
542 µM 11.2592 
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Figure 19 – Affinity of HcpR to heme – fluorescence generated titration binding 
curve.  
Heme dilution series was plotted and fit to a logarithmic curve. At 0.5 occupancy that 
substrate concentration is equivalent to the Kd. This yielded a Kd value of approximately 
155.6 µM 
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4.5 Analysis of NO binding  
 Figure 20 shows the spectral properties of heme reconstituted and reduced 
HcpR under anaerobic conditions before and after the addition of nitric oxide. The 
reduced sample displays a very sharp Soret peak at 392 nm that has a shoulder at 350 
nm. Upon the addition of NO the peak remains ~392 however the shoulder at 350 nm is 
not retained. There is also a slight but reproducible shift in the peak at 620 to 569 upon 
the addition of NO.      
 Resonance Raman spectroscopy further elucidated the properties of NO binding 
to HcpR. A series of resonance Raman spectra of the sample before and after the 
addition of NO is displayed in Figure 21. The polarization and depolarization 
components are also displayed. Among other characteristics of the graph, the most 
prominent is the shift at the 1362 cm-1 position to 1376 cm-1 position after addition of 
NO. Designated as the v4 band, these regions have been shown to be sensitive to XO 
binding in other heme proteins. Other vibrational markers appear as well, v3 at 1508 cm-
1, v2 at 1584 cm-1 and   v10 at 1646 cm-1. The peaks in these regions have been shown to 
be characteristic of NO binding in cytochrome c and hemoglobin (Spiro, Strekas 1974, 
Andrew, Green et al. 2001). Furthermore, these would indicate that there is a 5 
coordination binding of NO to a ferrous heme. In the low frequency region, the 
appearance of a peak at the 535 cm-1 region is most likely the v(Fe-NO) mode. This 
frequency is in the expected range for a 5 coordinate Fe(II)NO heme, as opposed to a 6 
coordinate Fe(II)NO heme which gives a frequency closer to 550 cm-1 (Tomita, Hirota et 
al. 1999). The change in peak intensity at the 756 cm-1 region has been shown to 
change in the binding of NO to cytochrome c. 
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Figure 20 – Anaerobic UV-Vis spectrum of HcpR – with NO. 
Reconstituted HcpR was reduced using dithionite and scanned from 300-700 nm to 
yield Fe3+ HcpR (oxidized line). NONOate was used to produce an excess of NO. The 
reduced sample was then incubated with an excess of NO (NONOate line). Addition of 
NO yields a species with a similar profile to the Fe2+ heme.  
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Figure 21 – Resonance Raman Spectrum of HcpR 
Reconstituted HcpR was incubated with dithionite under anaerobic conditions. The 
Raman spectrum was generated under anaerobic conditions. The nitrosylated sample 
was generated using an excess of NONOate dissolved in buffer and added to the 
sample. Panel A – HcpR without NO; Panel B – HcpR with NO added 
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4.6 Structural analysis of HcpR with Small Angle X-ray Scattering 
 Table 4 shows the structural parameters of the different forms of HcpR as 
determined by SAXS experiments. Figures 22-24 shows the scattering profiles log I(q) 
vs. S and Guinier plots (inset) for the Apo-, heme-, and DNA- form of the protein. The 
scattering profile for each form of HcpR shows a typical profile of a globular protein with 
a cylindrical shape. The Apo-HcpR sample shows a pure, mono-disperse sample with 
no aggregation. However, in the Heme-HcpR sample there is evidence in the scattering 
profile that the aggregation is occurring. Guinier analysis of the scattering data for the 
Apo-HcpR gives an expected linear fit for a pure, monodisperse solution and yields a 
radius of gyration (Rg) of 27.65 ± 0.02 for the Apo form of the protein. This also is 
evident in the Kratky plots (Fig. 25). The Kratky plots are a good estimate of the overall 
stability and integrity of the sample. A completely folded protein will form a curve shape 
on the graph and a completely unfolded sample will have a logarithmic shaped graph. 
As can be seen in the samples, the Apo and DNA forms of HcpR appear to be in a fully 
folded state, however, the heme form appears to be partially unfolded. This is not 
unexpected as the heme HcpR has had stability and precipitation problems.  
 The distance distribution functions were calculated using GNOM (Fig. 26) and 
shows the Apo form of the protein has a max diameter (Dmax) of approximately 83.1 
angstroms. The Dmax of the heme- and DNA- forms of the protein increases, however, 
the data from these samples is inconclusive. The stability and integrity of the protein is 
brought into question and aggregation issues were evident in the heme form of the 
sample.  
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 The Dmax and Rg of the Apo-HcpR suggests that HcpR is a longer, more 
cylindrical protein, as is predicted in the homology model. Furthermore, the molecular 
mass determination using Autoporod reveals that the molecular weight is approximately 
47 kDa. To compare the HcpR homology model with the SAXS data more in depth, the 
FoXs server was used to construct a theoretical scattering profile of the model (Fig 27). 
A theoretical curve of the monomer and dimer form of the model was generated. As can 
be seen, the dimer homology model theoretical scattering profile overlays very well with 
the Apo-HcpR scattering profile which supports previous data.  
 The ab initio reconstructed models were generated using DAMMIF and the 
GNOM log file. Ten models of each form of the protein were created and then clustered 
and scored; the best scoring model from the highest populated cluster was chosen. The 
models were constructed out of dummy residues in UCSF Chimera. As can be clearly 
seen in Figure 28, the shape of the Apo-HcpR ab initio model is comparable to the 
shape of the HcpR homology model. However there are clear differences: the N-
terminal heme binding domain appears to be more “stretched” in the ab initio model and 
more compact in the homology model. The heme-HcpR and DNA-HcpR ab initio models 
(Fig. 29-30) are not as well organized as the Apo-HcpR ab initio model. This is an 
expected result, given the partially unfolded state of the protein and the aggregation 
problems in the presence of heme. 
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Table 4 – Structural parameters from SAXS data 
 Apo-HcpR Heme-HcpR DNA-HcpR 
Rg 28.2 ± 0.15 29.3  ± 0.2 31.2 ± 0.2 
Dmax 94.5 Å 95.96Å 109.2 Å 
I(0) (from Guinier) 63.36 76.5 138.6 
I(0) (from P(r)) 63.89 78.5 136.4 
M.W.  47 kDa   
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Figure 22 – SAXS Scattering profile and Guinier plot for Apo-HcpR 
Scattering profile of the Apo-HcpR sample generated from merging samples of a same 
concentration. Inset shows the Guinier plot and associated linear fit (solid line) of the 
data in the Guinier region.  
 
 
 
 
 
   
66 
 
 
 
 
Figure 23 – Scattering profile and Guinier plot for Heme-HcpR 
Scattering profile of the heme-HcpR sample generated from merging samples of a 
same concentration. Inset shows the Guinier plot and associated linear fit (solid line) of 
the data in the Guinier region.  
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Figure 24 – Scattering profile and Guinier plot for DNA-HcpR 
Scattering profile of the DNA-HcpR sample generated from merging samples of a same 
concentration. Inset shows the Guinier plot and associated linear fit (solid line) of the 
data in the Guinier region.  
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Figure 25 – Kratky plots for HcpR 
Kratky plots derived from Figures 22-24 to test the protein stability and folded state of 3 
forms of HcpR: Apo-HcpR (A), Heme-HcpR (B), DNA-HcpR (C). The Kratky plot of the 
Apo-HcpR protein is characteristic of a globular protein.  
   
69 
 
 
Figure 26 – Distance Distribution functions P(r) 
The P(r) profiles for the different forms of HcpR: Apo-HcpR (A), Heme-HcpR (B), DNA-
HcpR (C). The profile for each form of HcpR was generated using a Dmax value 
calculated using the program DATGNOM, and is listed in Table 4 
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Figure 27 – Comparison to theoretical scattering profiles 
Theoretical scattering profile of dimer (A) and monomer (B) of Apo-HcpR homology 
models over-layed with Apo HcpR scatting profile. Theoretical profiles generated using 
the FoXs server.  
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Figure 28 – ab initio model of Apo-HcpR 
The ab initio shape reconstruction of Apo-HcpR, calculated from the scattering data, 
generated by DAMMIF. The models are represented using dummy atoms (A) and 
volume reconstruction (B). The HcpR homology model is compared to the ab initio 
dummy atom model (C).  
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Figure 29 – ab initio model of Heme-HcpR 
The ab initio shape reconstruction of Heme-HcpR, calculated from the scattering data, 
generated by DAMMIF. The models are represented using dummy atoms (top) and 
volume reconstruction (middle). The HcpR homology model is compared to the ab initio 
dummy atom model (bottom).  
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Figure 30 – ab initio model of DNA-HcpR 
The ab initio shape reconstruction of DNA-HcpR, calculated from the scattering data, 
generated by DAMMIF. The models are represented using dummy atoms (A) and 
volume reconstruction (B). The HcpR homology model is compared to the ab initio 
dummy atom model (C). 
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4.7 Promoter studies  
 There is no change in fluorescence when the bacteria are exposed to a testing 
range of 1 µM – 20 µM NONOate or nitrite for one hour. The basal level of expression of 
the P-glow gene was observed in TOP10 E. coli (Fig. 32). The P-Glow-BS2 plasmid 
contains a constitutive promoter. The PA-glow and PG-glow vector express very low 
amounts of the fluorescence protein. The P. Glow-Bs2 vector has a constitutive E. coli 
promoter upstream of the glow gene, causing a low basal expression of the fluorescent 
protein.  
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Figure 31 – NO and Nitrite stimulated activation of the hcp promoter by HcpR in E. 
coli. 
NO and nitrite dependent activation of the hcp promoter was measured using the BS2 
fluorescence reporter gene. The PG-glow vector and pACYC-hcpR vector were 
expressed simultaneously in E. coli and grown anaerobically in nitrites. The 
fluorescence was measured using a fluorescent plate reader.  
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Figure 32 – Base level expression of fluorescent reporter gene for different 
constructs 
Each construct was transformed into E. coli and grown anaerobically. The basal 
expression level of the fluorescent BS2 reporter gene was measured in each strain 
using a fluorescence plate reader. The P-glow-BS2 vector contains a constitutive E. coli 
promoter that has low basal level expression. 
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4.8 Crystallization of HcpR 
 After screening conditions, crystals of HcpR were obtained by oil drop diffusion 
method by combining 2 uL of protein solution (10 mg/mL protein in 100 mM NaCl, 25 
mM TRIS-HCl, 1 mM TCEP, pH 7.5) with 2 uL of screening solution (6% PEG 8k, 
100mM TRIS pH 8.0). The crystal grew in approximately 1 month with a rhombohedral 
shape. Cryo used was the mother liquor with 30% Glycerol added. 
 Crystal belongs to P orthorhombic crystal system. The unit cell parameters are: 
a= 93.23, b=129.41, c=150.52 A.  May be 2 dimer (4 monomer) per asymmetric unit 
with water content approximately 72%.    
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Figure 33 – HcpR Crystals from screening.  
Native, full length HcpR crystals grown at 20 mg/ml concentration in a 6% PEG 8k, 
100mM TRIS pH 8.0 solution. Crystals are 3-dimensional and orthorhombic in shape.  
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Figure 34 – HcpR Crystal diffraction pattern  
Diffraction pattern generated from the above (Fig. 33) crystals. Cryoprotectant used for 
crystals was 30% glycerol. Resolution of diffraction is 8-10 Angstroms.  
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Chapter 5 – Discussion  
 The nitrosative stress response is not well understood in Porphyromonas 
gingivalis and much of the phylum Bacteroidetes. These Gram negative, anaerobic 
bacteria are integral parts of the human microbiome. Reactive nitrogen species can 
reach high levels in the oral cavity and the host immune system utilizes NO synthases 
as an antimicrobial.  In order to inhabit the various parts of the body these microbes call 
home, they must have an efficient system in place to clear these toxic species. P. 
gingivalis is capable of withstanding the high concentrations of reactive nitrogen species 
and thus it is able to survive and grow in the oral cavity. It can also tolerate exposure to 
nitric oxide allowing it to survive the host immune response, which is elevated in the 
periodontal pockets during periodontitis. In P. gingivalis, Hcp is required for survival and 
bacterial growth in the presence of reactive nitrogen species. The FNR-like regulator, 
HcpR, activates the expression of Hcp in P. gingivalis in response to exposure to 
reactive nitrogen species. The exact mechanisms HcpR uses to modulate the 
expression of Hcp are not known. To efficiently regulate the nitrosative stress response, 
HcpR must effectively and efficiently bind the diatomic gas molecule, NO, and modulate 
the expression of its effector genes, which will clear the toxic species. In this study, we 
show that HcpR binds heme and in the presence of NO, the iron moiety is nitrosylated.   
 FNR-like transcription factors are found in many species of anaerobic bacteria 
and have been proven to play a role in the regulation of oxidative and nitrosative stress 
responses (although they are not limited to these functions). In the presence of oxides 
and N-oxides, they promote the expression of genes such as nir, nor, and nos which are 
responsible for detoxification and denitrification (Arai, Igarashi et al. 1995, Arai, Mizutani 
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et al. 2003). Bioinformatics studies revealed that HcpR shares a 69% sequence 
similarity to DNR, an FNR-like regulator found in Pseudomonas aeruginosa. Using DNR 
as a template, a working HcpR homology model was constructed. As most bacterial 
transcription factors (and all members of the FNR-like family), HcpR was modeled as a 
dimer.  
 Upon exposure to NO or nitrite, hcp is the most upregulated gene. The hcp gene 
encodes for a putative hydroxylamine reductase, although the gene products exact 
function(s) in P. gingivalis are still under much scrutiny. In other obligate and facultative 
anaerobes, Hcp has been shown to play an important role in NO and hydroxylamine 
reduction and detoxification (Rodionov, Dubchak et al. 2005, Chismon, Browning et al. 
2010). Previous studies have shown that hcp is a required gene for growth of P. 
gingivalis in the oral cavity, infection of the periodontal pockets, and invasion of host 
epithelial cells. 
 Initial purifications of HcpR using the pET30 His-tag method yielded a pure, 
highly expressed, recombinant protein. However, initial characterization revealed HcpR 
was a tetramer in solution. The initial native gel (Fig. 12), high-performance liquid 
chromatography (HPLC), and SAXS experiments produced results indicating that HcpR 
was a 100 kDa tetramer. This initial finding was both shocking and confusing. The 
recombinant protein that is produced by the pET30a plasmid yields a product that has a 
rather large, N-terminal tag (approximately 8 kDa) with an enterokinase cleavage site. 
Attempts to remove the tag using enterokinase were unsuccessful, thus we turned to 
the Halo-tag method of purifying the protein. The Halo-tag purification yields a very pure 
protein very quickly, however it is not a viable purification method to purify large 
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amounts of the protein. The modified-pET21 vector removes the T7 tag that is 
expressed on the N-terminal of the recombinant protein and adds a TEV protease 
cleavage site between the C-terminus of the protein and the 6x His tag. The modified-
pET21 vector allows for large scale purification of tag-less HcpR to be used in our 
assays. 
 As expected, HcpR is a dimer in solution after the removal of the affinity tag 
using either the Halo or pET21 recombinant proteins as confirmed by subsequent 
analytical ultracentrifugation and SAXS experiments. This puts HcpR in agreement with 
other members of the FNR-like family. 
 Binding of heme to the protein is a necessary step in the full activation of HcpR 
and is required for proper function of the protein. The exact mechanism by which HcpR 
binds heme is not known, however, it is possible HcpR is alone sufficient to bind heme. 
From our studies, it appears that HcpR does not bind heme efficiently under aerobic 
conditions. The TMBZ heme shift assay reveals that heme is binding to the protein, 
however, it is entirely possible that heme is binding nonspecifically. Heme is a very 
hydrophobic molecule and has a “sticky” nature to it at physiological pH, causing it to 
bind to places other than the heme binding domain. The fluorescence binding assay 
yields an extremely low affinity binding constant. This would require heme 
concentrations well above the physiological levels. It is possible that the drop in 
fluorescence is nonspecific binding of the heme, causing partial unfolding of the protein. 
This exposes the tryptophan residue to solvent, thus quenching the fluorescence. This 
is supported by the SAXS data. The Kratky plots of the heme samples indicate that 
there is partial unfolding of the protein. Furthermore, there is no Soret peak in the UV-
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Vis scan when heme binding is tested under aerobic conditions. The Soret peak is 
characteristic of most heme proteins and appears in the 400 nm range. It is possible 
that the presence of oxygen in the sample inhibits the binding of heme through 
interaction with the heme.  
 A very strong Soret peak appears upon doing the experiment under anaerobic 
conditions.  The anaerobic, resonance Raman spectrum also reveals the 4 vibrational 
modes that are common among heme proteins. These peaks do not arise from 
unbound, free heme in solution. Taken together, this indicates that aerobic conditions 
inhibit heme binding in some unknown way. It is possible that the free heme in solution 
is coordinating oxygen molecules between two heme molecules, thus inhibiting the 
binding of heme to the protein. By removing the competition from oxygen, this frees up 
heme to bind. Also, it is possible that the use of heme derived from hemin may be 
causing some unknown binding problems.  
 The oxidations state of the iron also appears to affect the Soret peak. Although 
the exact mechanism is not well understood, dithionite is used to oxidize ferrous iron to 
the ferric form. Addition of dithionite to the sample creates a shoulder on the Soret peak 
at approximately 350 nm, there is also a shift in the minor peak at the ~620 nm. The 
Soret peak arises from an electron dipole moment that allows a π to π* transition of the 
porphyrin ring, changing of the oxidation state of the iron changes the dipole moment 
and changes the energy of the peak (Shkirman, Solov’ev et al. 1999). We hypothesize 
that the addition of NO nitrosylates the iron, reducing Fe3+ and yielding Fe2+, causing a 
conformational change and activation of the protein. Addition of NO appears to reduce 
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the ferric iron to the ferrous form as predicted. The spectrum reverts to the ferrous form: 
the shoulder at 350 nm is lost and the peak at ~620 nm shifts back to ~570 nm.  
 Binding of NO is also supported by Resonance Raman spectroscopy. The 1362 
cm-1 peak is indicative of a high spin unbound form of the heme and the 1376 cm-1 peak 
is indicative of a low spin ligand-bound heme (this is a common theme among heme 
protein such as hemoglobin). The Raman spectrum of the un-nitrosylated, reduced 
sample appears to indicate the presence of a ferric, high spin heme. Upon addition of 
NO, there is a complete shift in the very large 1362 cm-1 peak to the 1372 cm-1peak, 
indicating the presence of a low spin, ligand bound heme. It should be noted that in the 
sample without NO there appears to be a mixed population of heme. In the un-
nitrosylated form of the protein, there is a smaller peak at 1376 cm-1 that can be seen in 
the polarized data that is overtaken by the much larger 1362 cm-1 peak. This could be 
due to a number of reasons: exposure to air can oxidize the reduced sample or the 
sample was never fully reduced by the dithionite.  
 The oxidation state of the heme may play a role in binding specificity for the 
protein. Oxygen and carbon monoxide cannot bind ferric heme; NO is the only diatomic 
gas molecule that is capable of binding to ferric heme. This is due the contraction of the 
dπ orbitals in Fe(III), which disallows the binding of O2 or CO. However, the odd electron 
on NO can spontaneously transfer to Fe(III), producing a Fe(II)-NO+ resonance 
structure (Soldatova, Ibrahim et al. 2010). The Fe(II)-NO+ resonance structure can be 
reduced by OH- in solution. The anaerobic nature inside P. gingivalis promotes a 
reduced environment inside the bacterium (there is a semi-reduced environment in most 
bacteria). It is believed the oxidative stress response in P. gingivalis uses other 
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mechanisms to promote expression of the necessary gene to clear the reactive oxygen 
species. HcpR’s use of ferric heme discriminates the activation of the protein towards 
only activating in the presence of NO.  
 Although creating a crystal that yields a decent resolution has eluded us, it may 
be possible to obtain a decent resolution with the current crystal conditions if a large 
enough crystal can be grown. Diffraction from these crystals are better than those previously 
tested, if a bigger crystal can be obtained then a full x-ray data set with reasonable resolution is 
probable. The mosaicity is too high and a better cryo condition must be found: ethylene 
glycol, MPD, DMSO, and sucrose still have to be tested.  
 The SAXS scattering profile yields an ab initio model that is very alike in volume 
and shape to our homology model. With SAXS data, it is possible to insert inherent bias 
in the analysis of the data sets. The theoretical homology model scattering profiles 
generated matches our scattering profile, reinforcing our extrapolations made from the 
data in comparison to the homology model. These data indicate that the homology 
model may be used to solve the structure of the protein through molecular replacement.  
 The hcp promoter assay would be a valuable tool to analyze the biological 
significance of HcpR and probe the structure of HcpR for necessary components (such 
as residues vital for activation). However, using NO and nitrite, we saw no dose 
dependent change in the expression of the fluorescence reporter gene in the promoter 
studies. This is most likely due to an inefficiency of E. coli to express a gene under 
control of the P. gingivalis promoter. Phylogenetically speaking, E. coli and P. gingivalis 
are distant relatives, and the mechanisms and tools E. coli uses to express genes are 
different. The RNA polymerase of P. gingivalis is unrelated to the RNA polymerase of E. 
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coli (Klimpel, Clark 1990). Furthermore, E. coli primary sigma factor is considerably 
different than the primary sigma factor found in members of the phylum Bacteroidetes 
(Vingadassalom, Kolb et al. 2005). The FNR binding sites at E. coli promoters bear no 
resemblance to the HcpR binding site at the hcp promoter in P. gingivalis (Barnard, 
Green et al. 2003). The Bacteroidetes ribosomal binding site and mechanisms of 
translation are considerably different than those found in E. coli (Wegmann, Horn et al. 
2013). It is also very likely that the interactions that HcpR uses to recruit RNA 
polymerase and up-regulate expression of hcp are very different than the mechanisms 
FNR uses in E. coli. Taken together, there is not a lot E. coli and P. gingivalis have in 
common in terms of gene expression. Although unfortunate for our immediate studies, 
this suggests that the mechanisms used by P. gingivalis are novel and are unlike those 
found in E. coli.  
 Although we focus on HcpR’s regulation at the hcp promoter, it is possible and 
probable that HcpR regulates the expression of other genes necessary for detoxification 
and dentrification. We clarify one small aspect of P. gingivalis’ response to reactive 
nitrogen species, however, as a whole the process remains poorly understood. Real-
time PCR analysis and micro-array analysis reveal the modulation of a number of P. 
gingivalis genes when exposed to NO (Boutrin, Wang et al. 2012). Many of these genes 
are hypothetical, uncategorized, or unknown and could be directly involved in the stress 
response.  
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Conclusion 
 This work identifies important properties of HcpR, and how it regulates the stress 
response to NO in P. gingivalis. We show that HcpR is a transcription factor that exists 
as a dimer in solution and binds the heme cofactor. The properties and structure of 
HcpR is similar to those found in other members of the FNR-like family of transcription 
factors. The heme cofactor is a necessary component of the protein in its role as a 
sensor protein. Heme allows HcpR to recognize and specifically bind NO. Upon binding 
of NO, we show evidence that there is a switch in oxidation state of the iron. We 
hypothesize that NO binding leads to a conformational change in the structure of HcpR, 
activating the protein and allowing it to up-regulate expression at the hcp promoter. 
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